To identify whether the clinical significance of LOXL2 expression in pancreas cancer patients is associated with metastasis and EMT properties, we conducted an in vitro study of LOXL2 in pancreatic cancer cells. This evidence concerns the gene LOXL2 and pancreatic neoplasm.